Last updated on September 2020

Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis


Brief description of study

The purpose of this study is to assess the efficacy of etrasimod on clinical remission in participants with moderately to severely active ulcerative colitis (UC).

Clinical Study Identifier: NCT03996369

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.